Sfondo Header
L'angolo del dottorino
Contents
Search the site... Advanced search
✖

Single-ventricle heart

The single-ventricle heart encompasses a heterogeneous group of congenital heart diseases in which a single ventricular mass supports, or is intended to support, most of the work of the circulation. The expression does not necessarily mean that only one ventricular chamber exists: two ventricles may be present, but one is too small, inadequate, or connected in a way that prevents safe biventricular separation. The common denominator is a problem in the organization of circulation, whose solution depends on the individual anatomy and changes during growth.

The clinical pathway extends from fetal diagnosis to adult management and includes neonatal stabilization, possible staged interventions, surveillance between operations, and prevention of late consequences. Palliation may allow long survival and an active life, but it does not recreate two normal ventricular pumps. Understanding the relationship between anatomy, flows, and the stage of treatment is essential for interpreting oxygen saturation, symptoms, test results, and prognosis.

Etiology and pathogenesis: a common pathway arising from different anatomies

The term describes a functional outcome of cardiac development, not a single embryological disease. Abnormalities in the formation of atrioventricular connections, ventricular growth, septation, or alignment of the great arteries may prevent the use of two independent ventricles. A chamber may be small because of the original defect and reduced flow through it during fetal life; in other cases, the problem primarily concerns valves, connections, and the feasibility of creating usable inflow and outflow pathways. It would therefore be inaccurate to reduce all these presentations to a failure of separation of the embryonic ventricle.

The genetic basis is variable. Chromosomal abnormalities, monogenic variants, laterality defects, or multifactorial predisposition not attributable to a single defect may be present. The extracardiac context is relevant both to reproductive counseling and to outcome assessment: renal, neurological, ciliary, or syndromic anomalies may alter vulnerability and care needs. Genetic investigations are guided by phenotype and family history and must be accompanied by an explanation of their limitations: an uninformative result does not rule out a hereditary component.

Distinguishing single-ventricle anatomy from single-ventricle physiology helps prevent misunderstandings. The former concerns chamber connections and structure; the latter concerns how blood is actually distributed. A heart with complex anatomy may sometimes be considered for biventricular repair, whereas a heart with two identifiable chambers may require single-ventricle palliation. The choice is not based on the diagnostic name alone, but on dimensions, function, valves, coronary arteries, outflow tracts, and the hemodynamic cost of possible reconstruction.

The monographs on single ventricle and double-inlet left ventricle describe the specific anatomical combinations. The general overview must instead clarify why patients with different diagnostic labels may share a strategy and why patients with the same diagnosis may require different initial interventions. The morphology of the dominant ventricle contributes to risk without replacing assessment of the entire system.

Borderline forms warrant multidisciplinary discussion. The possibility of ventricular recruitment, biventricular repair, or an intermediate strategy also depends on evolution over time and the center's experience. It is incorrect to regard single-ventricle palliation as merely a fallback when separating the circuits would impose obstructions, high filling pressures, or inadequate valves; it is equally incorrect to assume that every initially small ventricle is permanently unusable. The comparison must consider the foreseeable outcomes and risks of each pathway, not just the final number of functioning chambers.

Anatomy and pathophysiology across the stages of life

Anatomical description begins with situs and venous return, continues with atrioventricular and ventriculoarterial connections, identifies chamber morphology, and assesses outflow pathways. The dominant ventricle may have left, right, or less readily classifiable morphology. The accessory chamber is not irrelevant: it may contain a necessary outflow tract and communicate with the main chamber through a passage that is prone to narrowing. Competence of the atrioventricular valve and absence of obstruction to pulmonary venous return are just as important as ventricular contractile capacity.

Before palliative separation, pulmonary and systemic outputs depend on competing pathways. With extensive mixing, the dominant ventricle receives blood with different oxygenation levels and distributes it to the lungs and organs according to resistance and obstruction. Insufficient pulmonary blood flow causes hypoxemia; excessive flow may seemingly improve oxygen saturation while diverting useful output away from the systemic circulation and overloading the ventricle. An oximetry value alone does not measure oxygen delivery to tissues, which also depends on hemoglobin, cardiac output, and oxygen consumption. Single-ventricle physiology examines these relationships in the different configurations.

Birth changes the system abruptly: pulmonary vascular resistance progressively falls, placental support ends, and the ductus arteriosus tends to close. An acceptable fetal balance therefore does not guarantee neonatal stability. Pulmonary obstruction may make pulmonary blood flow dependent on the ductus; obstruction of systemic outflow or the aortic arch may make the ductus necessary for systemic perfusion. A restrictive atrial communication may impede venous return or mixing. The individual bottlenecks determine the initial urgency.

The superior cavopulmonary connection transfers part of systemic venous return directly to the lungs and reduces the volume load on the ventricular pump. Completion of Fontan circulation extends this principle to inferior venous return, with variations dictated by anatomy. Blood then reaches the pulmonary vascular bed without a subpulmonary ventricular pump; the dominant ventricle primarily supports the systemic circulation. This reorganization improves separation of flows, but ventricular filling remains dependent on how easily blood passes through the lungs and connections.

Low pulmonary vascular resistance, unobstructed venous and arterial pathways, limited filling pressures, and a competent atrioventricular valve become central conditions. Even a good ejection fraction does not exclude limited cardiac output: the ventricle may contract effectively but receive little blood. The venous pressure needed to sustain flow may also burden the liver and lymphatic system. Breathing, the skeletal muscle pump, and coordinated rhythm take on particular importance, explaining why exercise capacity and tolerance of physiological stress are not fully described by a resting echocardiogram.

Clinical manifestations and needs from fetal life to adulthood

The clinical history must identify the stage of circulation before symptoms can be interpreted. The original diagnosis, operations, prosthetic materials, catheterizations, usual oxygen saturation, medications, growth trajectory, and previous thrombotic or arrhythmic events are essential. Two patients described as having a “single ventricle” may have an undivided circulation, a systemic-to-pulmonary shunt, a superior cavopulmonary connection, or a completed Fontan circulation. The significance of cyanosis, venous pressure, and treatment changes radically between these conditions.

In newborns, manifestations include cyanosis, feeding difficulties, tachypnea, hypoperfusion, or deterioration after ductal closure. In infants, pulmonary overcirculation may present with sweating during feeds, fatigue, poor growth, and apparently recurrent respiratory infections. Oxygen saturation that is not particularly low does not exclude low systemic output. Reduced milk intake, faltering growth, or a change from usual values may precede overt heart failure.

During the intervals between interventions, particularly in shunt-dependent circulations, stability must be actively verified. Home-monitoring programs combine weight, feeding, oxygen saturation when indicated, and rapid contact with the specialist center. This does not mean transferring responsibility for diagnosis to the family, but establishing an organized response to warning signs. Limits and thresholds must be prescribed for the individual circulation: generic values may cause unnecessary alarm or delay recognition of a significant change.

In children and adolescents, exercise tolerance, school attendance, motor development, attention, executive functions, and emotional adjustment become prominent. School performance does not simply reflect general intelligence: selective difficulties may become apparent when organizational demands increase. Genetic vulnerability, fetal circulation, perioperative conditions, and the environment all contribute to outcomes, without every difficulty being attributable to a single intervention. Longitudinally organized neurodevelopmental assessment allows targeted support.

In adults, history taking explores changes in functional capacity, palpitations, syncope, edema, abdominal distension, persistent diarrhea, coughing up bronchial material, and bleeding. Progressive adaptation to lower activity levels may mask deterioration: merely asking whether the patient “feels well” is insufficient. Work, sexual health, contraception, reproductive intentions, treatment adherence, and psychological well-being must also be addressed as routine components of care.

The physical examination integrates oxygen saturation and its evolution, growth or body composition, heart rate and rhythm, blood pressure, peripheral perfusion, pulses, auscultation, the liver, edema, and ascites. Findings must be compared with the surgical configuration: a continuous murmur may result from a shunt, reduced saturation from a fenestration, and venous pressure from a cavopulmonary connection. Comparison with usual values is helpful, but should not lead to normalization of new symptoms or signs of progressive congestion.

Diagnosis and integrated assessment of the circulation

Fetal echocardiography defines the anatomy, follows changes in chamber and valve development, and identifies features that may make postnatal care urgent. Planning the delivery depends on the risk of instability and the availability of cardiology and cardiac surgical care; fetal diagnosis alone does not mandate preterm delivery or a universally applicable obstetric approach. Counseling must distinguish what is already established from what can only be clarified during the postnatal transition.

After birth, segmental echocardiography is the first tool used to assess connections, dimensions, function, valves, communications, and gradients. Reassessment after each stage is essential because surgery changes loading conditions and flow pathways. Some obstructions become apparent only with growth or a reduction in volume loading; others may be underestimated when flow is low. The significance of a Doppler gradient must therefore be interpreted alongside flow and the overall clinical picture, not as an independent indicator of severity.

Cardiovascular magnetic resonance imaging supplements the assessment of volumes, function, pulmonary arteries, conduits, and flow distribution when ultrasound does not resolve the clinical question. Unusual geometry and trabeculations make consistency of measurement methods important during subsequent examinations. CT angiography provides rapid imaging with high resolution, useful for specific vascular details or in patients unable to undergo MRI; in cavopulmonary circuits, the contrast protocol must avoid mixing artifacts that could be mistaken for thrombosis. The choice of examination should answer a concrete clinical question while balancing radiation exposure, sedation, and the expected information.

Catheterization enables pressure measurements, assessment of vascular resistance, and treatment of selected lesions, but its results are not independent of examination conditions. Anesthesia, ventilation, oxygen, hemoglobin, collateral vessels, and the method used to estimate flows may alter interpretation. Before proceeding to a surgical stage, or in the presence of deterioration, it is necessary to distinguish a correctable obstruction from a diffuse problem involving the pulmonary vascular bed, ventricular filling, or lymphatic circulation. An isolated number does not replace a comprehensive discussion of suitability for intervention.

Electrocardiography and prolonged monitoring look for conduction disorders and arrhythmias, including intermittent events. At an appropriate age, cardiopulmonary exercise testing quantifies the response to exertion and helps identify decline that might otherwise be masked by reduced activity. Blood tests and surveillance of the liver, kidneys, nutritional status, and plasma proteins investigate extracardiac consequences. Neither normal transaminase levels nor apparently preserved systolic function exclude a significant complication of the circulation.

The assessment must ultimately yield a clinically useful explanation: which element currently limits circulation, which abnormalities can be modified, and which additional information would change the strategy. Repeating tests without this synthesis increases the burden of care without necessarily improving decisions. During transfers between centers and from pediatric to adult care, an updated map of connections and a concise chronological record of procedures are often more informative than the diagnostic label alone.

Treatment, continuity of care, and prognosis

Neonatal stabilization protects systemic perfusion and adequate pulmonary blood flow. Prostaglandin E1 maintains ductal patency when the circulation depends on it; a restrictive atrial communication may require decompression. Ventilation, oxygen, fluids, and hemodynamic support must be tailored to the circuit: indiscriminately increasing pulmonary blood flow may worsen systemic perfusion. The first objective is to correct the immediate physiological threat and define a strategy, without treating all newborns with single-ventricle physiology as equivalent.

Initial treatment may increase inadequate pulmonary blood flow by means of a shunt or ductal stent, limit excessive flow through pulmonary artery banding, or reconstruct the systemic outflow pathway when obstructed. These interventions have different purposes and their own risks; they do not represent an identical sequence for everyone. Protecting the ventricle and pulmonary vascular bed in the initial stages affects the feasibility of effective cavopulmonary connections later. The need for another procedure may arise from growth and changes in a pathway, not necessarily from an error in the previous intervention.

Staged palliation aims to separate venous returns progressively and reduce ventricular loading. Deciding whether to proceed with Glenn, Kawashima, or Fontan requires favorable anatomy, adequate hemodynamic evaluation, and attention to comorbidities. Age and weight are components of the overall assessment, not sufficient criteria in themselves. Some patients do not reach the planned completion, while others require preparatory interventions or an alternative strategy; the pathway must remain open to reassessment when the clinical response differs from expectations.

Drug therapy is individualized and does not replace correction of a significant obstruction or major valvular regurgitation. Diuretics may reduce congestion, but excessive reduction of circulating volume can disadvantage a preload-dependent circulation. Treatments used in biventricular heart failure must not be transferred automatically: a randomized trial in infants with single-ventricle physiology did not demonstrate a general benefit of enalapril on growth and ventricular function. Pulmonary vasodilators are likewise reserved for selected profiles after the limiting mechanism has been identified.

Thromboembolic prevention depends on the stage, implanted materials, rhythm, and clinical history. In adults with Fontan circulation, previous thrombi or embolic events, sustained atrial arrhythmias, and atriopulmonary connections influence the need for anticoagulation; in other patients, aspirin or anticoagulation may be considered according to the individual risk-benefit balance. Drug choice and monitoring must also account for hepatic and renal function, bleeding, and the ability to adhere to treatment. There is no single antithrombotic prescription valid from birth for every single-ventricle congenital heart defect.

Continuity of care encompasses nutrition, rehabilitation, individualized physical activity, oral health, vaccination, development, and family support. Activity compatible with the clinical profile helps maintain muscular capacity and social participation; indiscriminate restriction may promote deconditioning. Transition to adult care is a gradual process of acquiring skills, not simply sending a referral letter: young people must understand their anatomy, recognize warning signs, and know how to contact their specialist center.

Reproductive counseling should precede pregnancy. In Fontan circulation, risk depends on ventricular function, oxygen saturation, rhythm, congestion, extracardiac complications, and antithrombotic therapy; good independence in daily life is not enough to establish that pregnancy is low risk. An experienced team coordinates congenital cardiology, obstetrics, and other necessary specialties, and also discusses contraception and alternatives. Counseling must distinguish maternal cardiovascular risk, fetal outcomes, and the risk of recurrence of congenital heart disease.

Prognosis must be expressed in relation to the starting point. Survival after completed Fontan circulation describes patients who have already survived diagnosis, the first intervention, and high-risk intervals; it is not equivalent to the probability of survival for all newborns considered for palliation. National cohorts document differences associated with ventricular morphology, but do not demonstrate that this factor acts independently of all associated anomalies and therapeutic choices. Surgical era, selection, length of follow-up, and access to care limit the transfer of percentages to an individual patient.

When palliation no longer sustains adequate circulation, evaluation for transplantation should begin before multiorgan deterioration limits the options. Transplantation is a specialist strategy with anatomical, immunological, and systemic limitations, not an automatic final stage. In advanced situations, goals of care, symptom management, and the patient's priorities should also be discussed alongside interventional options.

Complications and surveillance of systemic consequences

Complications change over time. In the early stages, instability of the flow balance, shunt thrombosis or stenosis, systemic obstruction, feeding difficulties, and vulnerability between stages predominate. After cavopulmonary connection, circuit patency, pulmonary pressure, ventricular function, the atrioventricular valve, and rhythm become central. Clinical changes may arise from a technically correctable lesion; regarding them as an inevitable consequence of a “single ventricle” risks delaying useful treatment.

Arrhythmias, systolic or diastolic dysfunction, and valvular regurgitation can reinforce one another. Loss of atrioventricular synchrony or persistent tachycardia reduces filling and output; congestion and dilatation in turn promote new arrhythmias. Rhythm treatment must therefore be accompanied by a search for hemodynamic causes and assessment of surgical access routes and scars. A technically complex electrophysiological procedure requires a center with specific experience.

Late oxygen desaturation may result from a fenestration, venovenous collaterals, pulmonary arteriovenous malformations, obstructions, or respiratory disease. Closing a communication may improve oxygenation but also remove a decompression pathway, worsening venous pressure or cardiac output. For this reason, the goal is not an isolated saturation value but an overall improvement in circulation. Anomalies of hepatic venous return and its distribution to the lungs are particularly relevant after a Kawashima procedure.

Fontan circulation failure includes different phenotypes: low output, congestion, arrhythmias, lymphatic abnormalities, or combinations of these problems. It may develop even without a marked reduction in ejection fraction. Surveillance includes the liver, kidneys, nutritional status, and hematological system and interprets test findings in a context where chronic congestion and reduced reserve may precede major symptoms.

Protein-losing enteropathy after Fontan and plastic bronchitis after Fontan are distinct manifestations that may share impaired lymphatic drainage. Edema and hypoalbuminemia in the former, and coughing and expectoration of bronchial casts in the latter, require specific assessment, together with a search for circuit obstructions. Not all forms respond to reducing congestion alone, and specialized lymphatic investigations and treatments may be needed.

Finally, surveillance must recognize neurodevelopmental, psychological, and social problems rather than reducing care to preventing the next intervention. Quality of life also depends on the opportunity to study, work, build relationships, and participate in decisions. A program shared between pediatric cardiology, adult congenital heart disease specialists, and community healthcare services brings these goals together and makes timely recognition of complications more likely.

References
  1. Rychik J et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation. 2019;140(6):e234-e284.
  2. Gurvitz M et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2026;87(7):822-976.
  3. Pierpont ME et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation. 2018;138(21):e653-e711.
  4. Anderson RH et al. Development of the heart: (2) Septation of the atriums and ventricles. Heart. 2003;89(8):949-958.
  5. Dalén M et al. Long-Term Survival After Single-Ventricle Palliation: A Swedish Nationwide Cohort Study. Journal of the American Heart Association. 2024;13(6):e031722.
  6. Khalil M et al. Acute therapy of newborns with critical congenital heart disease. Translational Pediatrics. 2019;8(2):114-126.
  7. Donofrio MT et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-2242.
  8. Baumgartner H et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563-645.
  9. Rudd NA et al. Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association. Journal of the American Heart Association. 2020;9(16):e014548.
  10. Sood E et al. Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association. Circulation. 2024;149(13):e997-e1022.
  11. Moon-Grady AJ et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2023;36(7):679-723.
  12. Fratz S et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):51.
  13. Hernández-Madrid A et al. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018;20(11):1719-1753.
  14. Hsu DT et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122(4):333-340.
  15. De Backer J et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46(43):4462-4568.
  16. Peled Y et al. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. Journal of Heart and Lung Transplantation. 2024;43(10):1529-1628.e54.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.